New combo therapy shows promise for Tough-to-Treat cancer spread

NCT ID NCT06376292

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a combination of whole-brain radiation and a chemotherapy drug (thiotepa) injected into the spinal fluid for people with solid tumors that spread to the lining of the brain and spinal cord. 58 participants received this treatment along with their regular cancer therapy. The goal was to see if the combination was safe and effective at controlling the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR LEPTOMENINGEAL METASTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Second Affiliated Hospital of Zhejiang University

    Hangzhou, Zhejiang, 310000, China